Progress in the care of common inherited atherogenic disorders of apolipoprotein B metabolism

Research output: Contribution to journalReview article

21 Citations (Scopus)


© 2016 Macmillan Publishers Limited.
Familial hypercholesterolaemia, familial combined hyperlipidaemia (FCH) and elevated lipoprotein(a) are common, inherited disorders of apolipoprotein B metabolism that markedly accelerate the onset of atherosclerotic cardiovascular disease (ASCVD). These disorders are frequently encountered in clinical lipidology and need to be accurately identified and treated in both index patients and their family members, to prevent the development of premature ASCVD. The optimal screening strategies depend on the patterns of heritability for each condition. Established therapies are widely used along with lifestyle interventions to regulate levels of circulating lipoproteins. New therapeutic strategies are becoming available, and could supplement traditional approaches in the most severe cases, but their long-term cost-effectiveness and safety have yet to be confirmed. We review contemporary developments in the understanding, detection and care of these highly atherogenic disorders of apolipoprotein B metabolism.
Original languageEnglish
Pages (from-to)467-484
Number of pages18
JournalNature Reviews Endocrinology
Issue number8
Publication statusPublished - Aug 2016


Cite this